documents: FDA-2023-N-0061-0044

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-N-0061-0044 FDA FDA-2023-N-0061 Memorandum - Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act (Proposed Rule) Other Memorandum 2024-11-06T05:00:00Z 2024 11 2024-11-06T05:00:00Z   2024-11-06T17:00:18Z   0 0 09000064867ffe78

Links from other tables